Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 10 2021
Historique:
pubmed: 12 6 2021
medline: 16 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

The association between COVID-19 symptoms and SARS-CoV-2 viral levels in children living in the community is not well understood. To characterize symptoms of pediatric COVID-19 in the community and analyze the association between symptoms and SARS-CoV-2 RNA levels, as approximated by cycle threshold (Ct) values, in children and adults. This cross-sectional study used a respiratory virus surveillance platform in persons of all ages to detect community COVID-19 cases from March 23 to November 9, 2020. A population-based convenience sample of children younger than 18 years and adults in King County, Washington, who enrolled online for home self-collection of upper respiratory samples for SARS-CoV-2 testing were included. Detection of SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction (RT-PCR) from participant-collected samples. RT-PCR-confirmed SARS-CoV-2 infection, with Ct values stratified by age and symptoms. Among 555 SARS-CoV-2-positive participants (mean [SD] age, 33.7 [20.1] years; 320 were female [57.7%]), 47 of 123 children (38.2%) were asymptomatic compared with 31 of 432 adults (7.2%). When symptomatic, fewer symptoms were reported in children compared with adults (mean [SD], 1.6 [2.0] vs 4.5 [3.1]). Symptomatic individuals had lower Ct values (which corresponded to higher viral RNA levels) than asymptomatic individuals (adjusted estimate for children, -3.0; 95% CI, -5.5 to -0.6; P = .02; adjusted estimate for adults, -2.9; 95% CI, -5.2 to -0.6; P = .01). The difference in mean Ct values was neither statistically significant between symptomatic children and symptomatic adults (adjusted estimate, -0.7; 95% CI, -2.2 to 0.9; P = .41) nor between asymptomatic children and asymptomatic adults (adjusted estimate, -0.6; 95% CI, -4.0 to 2.8; P = .74). In this community-based cross-sectional study, SARS-CoV-2 RNA levels, as determined by Ct values, were significantly higher in symptomatic individuals than in asymptomatic individuals and no significant age-related differences were found. Further research is needed to understand the role of SARS-CoV-2 RNA levels and viral transmission.

Identifiants

pubmed: 34115094
pii: 2780963
doi: 10.1001/jamapediatrics.2021.2025
pmc: PMC8491103
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e212025

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007044
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007233
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
N Engl J Med. 2020 Jul 9;383(2):185-187
pubmed: 32356944
EClinicalMedicine. 2020 Jun 26;24:100433
pubmed: 32766542
Clin Infect Dis. 2021 Jun 15;72(12):2215-2217
pubmed: 32710743
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Pediatrics. 2020 Aug;146(2):
pubmed: 32457212
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Lancet. 2021 Jan 9;397(10269):93-94
pubmed: 33347812
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452
pubmed: 32780793
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
Emerg Infect Dis. 2020 Oct;26(10):2494-2497
pubmed: 32603290
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33093026
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392
pubmed: 33031141
PLoS One. 2021 Apr 14;16(4):e0245423
pubmed: 33852576
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):596-608
pubmed: 32840614
JAMA Netw Open. 2020 Jul 1;3(7):e2016382
pubmed: 32697321
Lancet Infect Dis. 2021 May;21(5):617-628
pubmed: 33476567
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Sci Rep. 2021 Feb 4;11(1):3044
pubmed: 33542262
Emerg Infect Dis. 2020 Oct;26(10):2497-2499
pubmed: 32497001
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Clin Infect Dis. 2020 Nov 03;:
pubmed: 33141180
Clin Infect Dis. 2021 Jul 1;73(1):148-150
pubmed: 32761228
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Clin Infect Dis. 2021 Oct 5;73(7):1805-1813
pubmed: 33185244
J Glob Health. 2020 Jun;10(1):011101
pubmed: 32612817
Clin Infect Dis. 2021 Jun 1;72(11):e761-e767
pubmed: 32986120
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Br J Anaesth. 2020 Sep;125(3):e330-e332
pubmed: 32534738
Clin Infect Dis. 2021 Jun 15;72(12):e970-e977
pubmed: 33180914
J Clin Microbiol. 2021 Apr 20;59(5):
pubmed: 33563599
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Clin Infect Dis. 2021 Jun 15;72(12):e1146-e1153
pubmed: 33283240
J Pediatr. 2020 Dec;227:45-52.e5
pubmed: 32827525
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447

Auteurs

Erin Chung (E)

Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle.

Eric J Chow (EJ)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.

Naomi C Wilcox (NC)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.

Roy Burstein (R)

Institute for Disease Modeling, Seattle, Washington.

Elisabeth Brandstetter (E)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.
Brotman Baty Institute for Precision Medicine, Seattle, Washington.

Peter D Han (PD)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.

Kairsten Fay (K)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Brian Pfau (B)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.

Amanda Adler (A)

Seattle Children's Research Institute, Seattle, Washington.

Kirsten Lacombe (K)

Seattle Children's Research Institute, Seattle, Washington.

Christina M Lockwood (CM)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle.

Timothy M Uyeki (TM)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Jay Shendure (J)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.
Howard Hughes Medical Institute, Seattle, Washington.

Jeffrey S Duchin (JS)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.
Public Health-Seattle & King County, Seattle, Washington.

Mark J Rieder (MJ)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.

Deborah A Nickerson (DA)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.

Michael Boeckh (M)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Michael Famulare (M)

Institute for Disease Modeling, Seattle, Washington.

James P Hughes (JP)

Department of Biostatistics, University of Washington, Seattle.

Lea M Starita (LM)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.

Trevor Bedford (T)

Brotman Baty Institute for Precision Medicine, Seattle, Washington.
Department of Genome Sciences, University of Washington, Seattle.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Janet A Englund (JA)

Seattle Children's Research Institute, Seattle, Washington.

Helen Y Chu (HY)

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH